This inventor holds 4 USPTO granted patents and 4 published patent applications. Top assignee: Massachusetts Institute of Technology. Active years: 2017-2024.
Company Filing History:
Years Active: 2017-2024
Title: Jesse C Patterson: Innovator in Cancer Treatment
Introduction
Jesse C Patterson is a notable inventor based in Natick, MA (US), recognized for her contributions to cancer treatment through innovative pharmaceutical compositions. With a total of 4 patents, Patterson has made significant strides in developing combination therapies aimed at improving patient outcomes in oncology.
Latest Patents
Patterson's latest patents focus on combination therapies and methods for treating cancer. These patents disclose pharmaceutical compositions that include an effective amount of an antiandrogen or androgen antagonist in combination with a Plk inhibitor. The methods outlined in these patents demonstrate that the administration of these active agents can effectively reduce cancer cell proliferation or viability in subjects with cancer. This approach can be as effective, or even more so, than administering either active agent alone. The active agents can be administered together or separately, providing flexibility in treatment options. Additionally, the patents include methods for selecting and treating subjects with various cancers, including castration-resistant prostate cancer, androgen receptor-positive breast cancers, and pancreatic cancers.
Career Highlights
Jesse C Patterson is affiliated with the Massachusetts Institute of Technology, where she continues to advance her research in cancer therapies. Her work is characterized by a commitment to developing innovative solutions that address critical challenges in cancer treatment.
Collaborations
Patterson collaborates with Michael B Yaffe, a fellow researcher who shares her dedication to improving cancer treatment methodologies. Their partnership exemplifies the collaborative spirit of innovation in the field of oncology.
Conclusion
Jesse C Patterson's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the pharmaceutical field. Her work continues to pave the way for advancements in cancer therapies, ultimately benefiting patients worldwide.